title: Activity and content of antioxidant enzymes in prostate tumors.
abstract: OBJECTIVE
  To investigate the antioxidant enzyme system in blood of men with benign hyperplasia of prostate (BHP) and with prostate adenocarcinoma (CaP).
  
  
  METHODS
  The spectrophotometrical methods were applied to study content and activity changes of superoxide-dismutase (SOD), catalase (CAT), ceruloplasmin (Cp), tripeptide glutathione (GSH), glutathione-peroxidase (GSH-Px), and glutathione-reductase (GR). Lipid peroxidation was evaluated using thiobarbituric acid (TBA)-test. Blood plasma and erythrocytes of men with prostate tumors served as the material for the studies; n = 15 for each group.
  
  
  RESULTS
  SOD activity was increased in BHP (24.65 +/- 1.20 U/microl) and decreased in CaP (11.45 +/- 0.89 U/microl), CAT activity remained unaltered in BHP (12.41 +/- 0.85 mcat/ml) and was slightly declined in CaP (9.52 +/- 0.56 mcat/ml). Cp was increased in both kind of tumors, especially in CaP (54.27 +/- 7.22 mg%), as well as GSH (0.736 +/- 0.07 microM/l) and GR (0.031 +/- 0.002 microM/g.Hemogl/min). GSH-Px was sharply increased in BHP (0.67 +/- 0.05 microM/g.Hemogl/min) and reduced in CaP (0.16 +/- 0.01 microM/g.Hemogl/min).
  
  
  CONCLUSIONS
  The development of BHP reflects relatively weakly on blood system as activity and content of antioxidant enzymes are not revealing marked changes in this disease. The significant changes are revealed in case of CaP, showing the reduced functional state of blood antioxidant enzyme system.
authors.affiliation: Faculty of Exact and Natural Sciences, Institute of Biology, Iv. Javakhishvili Tbilisi State University, Tbilisi, Georgea. nana@biomed.ge
authors.forename: N
authors.initials: N
authors.lastname: Kotrikadze
authors.forename: M
authors.initials: M
authors.lastname: Alibegashvili
authors.forename: M
authors.initials: M
authors.lastname: Zibzibadze
authors.forename: N
authors.initials: N
authors.lastname: Abashidze
authors.forename: T
authors.initials: T
authors.lastname: Chigogidze
authors.forename: L
authors.initials: L
authors.lastname: Managadze
authors.forename: K
authors.initials: K
authors.lastname: Artsivadze
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000201:enzymology / Q000473:pathology; D000368:Aged; D000975:Antioxidants / Q000378:metabolism*; D002374:Catalase / Q000378:metabolism; D002570:Ceruloplasmin / Q000378:metabolism; D004912:Erythrocytes / Q000201:enzymology*; D005978:Glutathione / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000378:metabolism; D005980:Glutathione Reductase / Q000378:metabolism; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000378:metabolism*; D011470:Prostatic Hyperplasia / Q000097:blood / Q000201:enzymology* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000097:blood / Q000201:enzymology* / Q000473:pathology; D013482:Superoxide Dismutase / Q000378:metabolism; D017392:Thiobarbituric Acid Reactive Substances
chemical_list: D000975:Antioxidants; D017392:Thiobarbituric Acid Reactive Substances; D010088:Oxidoreductases; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D002570:Ceruloplasmin; D005980:Glutathione Reductase; D005978:Glutathione